These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9020106)

  • 21. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
    Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic studies on the DNA linking activity of Epstein-Barr nuclear antigen 1.
    Avolio-Hunter TM; Frappier L
    Nucleic Acids Res; 1998 Oct; 26(19):4462-70. PubMed ID: 9742250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
    Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
    Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70.
    Wang H; Bu L; Wang C; Zhang Y; Zhou H; Zhang X; Guo W; Long C; Guo D; Sun X
    Cell Death Dis; 2018 Jun; 9(7):734. PubMed ID: 29959331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers.
    Jiang L; Xie C; Lung HL; Lo KW; Law GL; Mak NK; Wong KL
    Theranostics; 2018; 8(19):5307-5319. PubMed ID: 30555548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromatin-binding regions of EBNA1 protein facilitate the enhanced transfection of Epstein-Barr virus-based vectors.
    Howden SE; Wardan H; Voullaire L; McLenachan S; Williamson R; Ioannou P; Vadolas J
    Hum Gene Ther; 2006 Aug; 17(8):833-44. PubMed ID: 16942443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.
    Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Tsurumi T
    J Biol Chem; 2004 Dec; 279(52):54817-25. PubMed ID: 15498777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear import of HPV11 L1 capsid protein is mediated by karyopherin alpha2beta1 heterodimers.
    Merle E; Rose RC; LeRoux L; Moroianu J
    J Cell Biochem; 1999 Sep; 74(4):628-37. PubMed ID: 10440932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization.
    Kim SY; Song KA; Kieff E; Kang MS
    Biochem Biophys Res Commun; 2012 Jul; 424(2):251-6. PubMed ID: 22735264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
    Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth.
    Messick TE; Smith GR; Soldan SS; McDonnell ME; Deakyne JS; Malecka KA; Tolvinski L; van den Heuvel APJ; Gu BW; Cassel JA; Tran DH; Wassermann BR; Zhang Y; Velvadapu V; Zartler ER; Busson P; Reitz AB; Lieberman PM
    Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2).
    Nayyar VK; Shire K; Frappier L
    J Cell Sci; 2009 Dec; 122(Pt 23):4341-50. PubMed ID: 19887584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A karyopherin alpha2 nuclear transport pathway is regulated by glucose in hepatic and pancreatic cells.
    Cassany A; Guillemain G; Klein C; Dalet V; Brot-Laroche E; Leturque A
    Traffic; 2004 Jan; 5(1):10-9. PubMed ID: 14675421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency.
    Wang Y; Du S; Zhu C; Wang C; Yu N; Lin Z; Gan J; Guo Y; Huang X; He Y; Robertson E; Qu D; Wei F; Cai Q
    PLoS Pathog; 2020 Mar; 16(3):e1008447. PubMed ID: 32176739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA.
    Reznichenko O; Quillévéré A; Martins RP; Loaëc N; Kang H; Lista MJ; Beauvineau C; González-García J; Guillot R; Voisset C; Daskalogianni C; Fåhraeus R; Teulade-Fichou MP; Blondel M; Granzhan A
    Eur J Med Chem; 2019 Sep; 178():13-29. PubMed ID: 31173968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2.
    Cao JY; Shire K; Landry C; Gish GD; Pawson T; Frappier L
    Mol Cell Biol; 2014 Jan; 34(2):246-58. PubMed ID: 24216761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
    Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
    J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of nuclear protein transport.
    Moroianu J
    Crit Rev Eukaryot Gene Expr; 1997; 7(1-2):61-72. PubMed ID: 9034715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.